Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Paul J. Hastings$480.3M
Market Cap • 25/04/20242015
(há 9 anos)
2020
(4 years ago)
NASDAQ
Listagem
South San Francisco
Sede • California163
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
NKTXSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.